Agenus, Inc. (AGEN)
3.79
-0.29
(-7.11%)
USD |
NASDAQ |
Dec 12, 16:00
3.795
0.00 (0.00%)
After-Hours: 20:00
Agenus Research and Development Expense (Quarterly): 23.60M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 12.98M |
| Cardiff Oncology, Inc. | 8.197M |
| Armata Pharmaceuticals, Inc. | 5.824M |
| AIM ImmunoTech, Inc. | 0.525M |
| Protalix Biotherapeutics, Inc. | 4.467M |